¹ß±âºÎÀüȯÀÚÀÇ ¾à¹°¹ß±â°Ë»ç¿¡ ¹ÌÄ¡´Â ¿µÇâÀÎÀÚ ºÐ¼®
Influencing Factors on Pharmacologic Erectile Response in Patients with Erectile Dysfunction
Á¤¿ì½Ä ( Chung Woo-Sik ) - ÀÌÈ¿©ÀÚ´ëÇб³ Àǰú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Abstract
¼·Ð
ÇØ¸éü³» Ç÷°üÀÛ¿ëÁ¦ÁÖ»ç¿ä¹ýÀº ¹ß±âºÎÀüȯÀÚÀÇ Áø´Ü°ú Ä¡·á¿¡ ÀÖ¾î °¡Àå ¸¹ÀÌ ÀÌ¿ëµÇ°í
ÀÖ´Â ¹æ¹ýÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±×·¯³ª ¾ç¼º¹ÝÀÀÀÌ ³ªÀ» ¶§¸¦ Á¦¿ÜÇϰí´Â °á°úÀÇ ÇØ¼®¿¡ ¾î·Á
¿òÀÌ ÀÖÀ¸¸ç µû¶ó¼ ½ÇÁ¦·Î ¹ß±â¹ÝÀÀ¿¡ ¿µÇâÀ» ÁÙ °ÍÀ¸·Î ÃßÁ¤µÇ´Â ÀÎÀÚµéÀÇ ¿µÇâÀ» È®ÀÎÇÑ
´Ù¸é À½¼º¹ÝÀÀÀÇ ¿øÀÎÀ» ¹àÈ÷´Â µ¥¿¡ µµ¿òÀÌ µÉ °ÍÀÌ°í ¶ÇÇÑ È¯ÀÚÀÇ Ä¡·á¹æÄ§ ¼³Á¤¿¡µµ Âü
°í°¡ µÉ ¼ö ÀÖÀ» °ÍÀÌ´Ù. Áï, ºÒ¿ÏÀü ȤÀº ¹«¹ÝÀÀÀ» º¸ÀÌ´Â °æ¿ì¿¡ ½ÇÁ¦·Î Ç÷°ü°è¿¡ ÀÌ»óÀÌ
ÀÖ¾î¼ÀÎÁö, ¾Æ´Ï¸é ½É¸®Àû ºÎ´ã¿¡ ÀÇÇÑ ÀϽÃÀûÀÎ °ÍÀÎÁöÀÇ °¨º°À» ¿äÇÏ°Ô µÇ¸ç, ½ÇÁ¦·Î ÀÌ
¸¦ ¸íÈ®È÷ °¨º°ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ¸·Î´Â Àç½Ãµµ¸¦ Çϰųª ´Ù¸¥ ÀÚ±ØÀ» º´¿ëÇÏ¿© ½É¸®Àû ºÎ´ã
À» ÃÖ¼ÒȽÃÄÑ º¸´Â ¹æ¹ýÀÌ °íÀÛÀÌ´Ù. ÀÌ·± Çö½Ç¿¡¼ ½ÇÁ¦·Î ¹ß±â¹ÝÀÀ¿¡ ¿µÇâÀ» ÁÙ °ÍÀ¸·Î
ÃßÁ¤µÇ´Â ÀÎÀÚµé°ú ½ÇÁ¦ ¹ÝÀÀÀÇ °á°ú¿ÍÀÇ »ó°ü°ü°è¸¦ ºÐ¼®ÇÏ¿© ¿µÇâÀÇ À¯¹«°¡ È®Àεȴٸé,
ÀÌ·¯ÇÑ ¿µÇâÀÎÀÚ¸¦ °¡Áø ȯÀÚ°¡ ºñÁ¤»ó ¹ß±â¹ÝÀÀÀ» º¸ÀÏ ¶§¿¡ ±×·¸Áö ¾ÊÀº ȯÀÚ¿¡ ºñÇÏ¿©
»ó´ëÀûÀ¸·Î À§ À½¼º¹ÝÀÀÀÇ °¡´É¼ºÀÌ Àû´Ù°í ÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ¸íÈ®ÇÑ °¨º°À» Á¦°øÇÏÁö´Â
¸øÇÏÁö¸¸ Â÷ÈÄÀÇ Áø·á¹æÄ§ÀÇ ¼³Á¤¿¡ ÀÖ¾î ÃæºÐÈ÷ Âü°íÇÒ ¸¸ÇÑ °¡Ä¡°¡ ÀÖÀ¸¸®¶ó »ý°¢µÈ´Ù.
ÀϹÝÀûÀ¸·Î ¼ú, ´ã¹è µîÀÇ ±âȣǰ, ´ç´¢, °íÇ÷¾Ð, °íÄÝ·¹½ºÅ×·ÑÇ÷Áõ, ½ÉÇ÷°üÁúȯ µîÀÇ Ç÷°ü
À§ÇèÀÎÀÚ µîÀÌ ¹ß±â·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ÃßÁ¤µÇ¾î ¿Ô´Ù. º» ¿¬±¸¿¡¼´Â ¾à¹°¹ß±â¹ÝÀÀ¿¡
¿µÇâÀ» ¹ÌÄ¡¸®¶ó ÃßÁ¤µÇ´Â »ó±â ÀÎÀÚµé°ú ÇÔ²² ¿¬·É, À¯º´±â°£, ÀÜ¿© ¹ß±â´É·Â µîÀ» Æ÷ÇÔÇÏ
¿© À̵é ÀÎÀÚµéÀÇ À¯¹« ȤÀº °®°í ÀÖ´Â Á¤µµ µî¿¡ µû¶ó ¾à¹°¿¡ ´ëÇÑ ¹ß±â¹ÝÀÀµµ¸¦ ºñ±³ °ü
ÂûÇÏ¿© ¹ß±â¹ÝÀÀ¿¡ ¿µÇâÀ» ÁÖ´Â ÀÎÀÚµéÀ» ã¾Æº¸°íÀÚ ÇÏ¿´´Ù.
Purpose: We examined the predictable determinants affecting satisfactory rigidity induced by PGE1 in patients with erectile dysfunction.
Materials and Methods: Two hundred and sixty eight consecutive impotent patients entered the study. The pharmacologic erectile response to intracavernosal injection of PGE1 10 §¶ were analysed according to several factors which were patient¡¯s age, duration of impotent symptom, quality of residual erectile function, smoking and alcohol
consumption history, and vascular risk factors of diabetes, hypertenstion, heart diseases and hypercholesterolemia.
Results: There was a significant decrease of erectile response to PCE1 in patients having vascular risk factors(p<0.01). Patient¡¯s age and quality of residual erectile function had an significant effect on pharmacologic erectile response (p<0.05). Other factors such as impotent duration and smoking/alcohol consumption did not reach
significant difference.
Conclusions: These data demonstrates that patient¡¯s age and their vascular risk factors have negative effect and residual erectile function has positive effect on the pharmacologic penile erection in patients with erectile dysfunction.
Ű¿öµå
Pharmacologic penile erection; Age; Vascular risk factors;
KMID :
0356419990170010017
DOI :
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸